| The treatment of primary orthostatic hypotension GM Hale, J Valdes, M Brenner Annals of Pharmacotherapy 51 (5), 417-428, 2017 | 47 | 2017 |
| Integration strategies of pharmacists in primary care-based accountable care organizations: a report from the accountable care organization research network, services, and … T Joseph, GM Hale, SM Eltaki, Y Prados, R Jones, MJ Seamon, C Moreau, ... Journal of Managed Care & Specialty Pharmacy 23 (5), 541-548, 2017 | 43 | 2017 |
| Impact of a pharmacist-managed heart failure postdischarge (bridge) clinic for veterans GM Hale, SL Hassan, SL Hummel, C Lewis, D Ratz, M Brenner Annals of Pharmacotherapy 51 (7), 555-562, 2017 | 41 | 2017 |
| High nitrogen during growth reduced glucoraphanin and flavonol content in broccoli (Brassica oleracea var. italica) heads RB Jones, M Imsic, P Franz, G Hale, RB Tomkins Australian Journal of Experimental Agriculture 47 (12), 1498-1505, 2007 | 38 | 2007 |
| Pharmacotherapy of Vasospastic Angina JR Harris, GM Hale, TW Dasari, NC Schwier Journal of Cardiovascular Pharmacology and Therapeutics, 1074248416640161, 2016 | 37 | 2016 |
| An evaluation of adverse drug reactions associated with antipsychotic use for the treatment of delirium in the intensive care unit GM Hale, SL Kane-Gill, L Groetzinger, PL Smithburger Journal of pharmacy practice 29 (4), 355-360, 2016 | 34 | 2016 |
| Effects of dopamine receptor antagonist antipsychotic therapy on blood pressure NH Gonsai, VH Amin, CG Mendpara, R Speth, GM Hale Journal of clinical pharmacy and therapeutics 43 (1), 1-7, 2018 | 32 | 2018 |
| β1-adrenoceptor Arg389Gly polymorphism confers differential β-arrestin-binding tropism in cardiac myocytes KA McCrink, A Brill, M Jafferjee, TR Valero, C Marrero, MM Rodriguez, ... Pharmacogenomics 17 (15), 1611-1620, 2016 | 21 | 2016 |
| Strategies for managing pharmacy experiential education during COVID-19 C Moreau, S Maravent, GM Hale, T Joseph Journal of Pharmacy Practice 34 (1), 7-10, 2021 | 20 | 2021 |
| Safety of high-intensity statins in the veteran population: atorvastatin 40 to 80 mg compared with rosuvastatin 20 to 40 mg B Stein, T Ward, G Hale, E Lyver Annals of Pharmacotherapy 54 (5), 405-413, 2020 | 16 | 2020 |
| Chronic obstructive pulmonary disease and heart failure self-management kits for outpatient transitions of care P Boylan, T Joseph, G Hale, C Moreau, M Seamon, R Jones The Consultant Pharmacist® 33 (3), 152-158, 2018 | 15 | 2018 |
| Atomoxetine for Orthostatic Hypotension in an Elderly Patient Over 10 Weeks: A Case Report GM Hale, M Brenner Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 35 (9 …, 2015 | 12 | 2015 |
| Treatment of adults with idiopathic recurrent pericarditis: novel use of immunotherapy NC Schwier, GM Hale, ML Davies Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 37 (3 …, 2017 | 11 | 2017 |
| Evaluating a pharmacist-led intervention on cardiovascular-and diabetes-related quality measures in a primary care-based accountable care organization T Joseph, G Hale, C Moreau, ED Rosario, N Logan, A Perez Journal of Pharmacy Practice 35 (3), 363-368, 2022 | 9 | 2022 |
| Evaluation of pharmacist impact within an interdisciplinary inpatient heart failure consult service S Blizzard, N Verbosky, B Stein, G Hale, N Patel, Y Chau, B Cave Annals of Pharmacotherapy 53 (9), 905-915, 2019 | 8 | 2019 |
| Improving Medication Adherence in an ACO Primary Care Office With a PharmacistLed Clinic: A Report From the ACORN SEED G Hale, C Moreau, T Joseph, J Phyu, N Merly, N Tadros, MM Rodriguez Journal of Pharmacy Practice 34 (6), 888-893, 2021 | 7 | 2021 |
| Effect of interprofessional collaboration on quality of life in elderly patients with cardiovascular disease GM Hale, T Joseph, S Maravent, D Stern, S Alameddine, K Stultz, ... Journal of Interprofessional Education & Practice 12, 25-28, 2018 | 6 | 2018 |
| Evaluating the effectiveness of atomoxetine for the treatment of primary orthostatic hypotension in adults H Patel, A Simpson, G Palevoda, GM Hale The Journal of Clinical Hypertension 20 (4), 794, 2018 | 6 | 2018 |
| Risks and benefits of low molecular-weight heparin and target-specific oral anticoagulant use for thromboprophylaxis in medically ill patients G Hale, M Brenner American Journal of Cardiovascular Drugs 15, 311-322, 2015 | 6 | 2015 |
| Antithrombotic therapy in peripheral artery disease: stepping in the right direction KR Hand, GM Hale American Journal of Cardiovascular Drugs 21 (5), 523-534, 2021 | 5 | 2021 |
